...
首页> 外文期刊>Journal of Radiation Research: Official Organ of the Japan Radiation Research Society >National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
【24h】

National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group

机译:日本减少强度干细胞移植前全体体外辐射的国家调查:日本辐射肿瘤学研究组

获取原文
获取原文并翻译 | 示例
           

摘要

Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI-RIST). Different institutes adopt different approaches for the administration of TBI-RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI-RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI-RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI-RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI-RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI-RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI-RIST in Japan and can assist future efforts to standardize TBI-RIST treatment methods and to design a future multicenter collaborative research study.
机译:减少强度干细胞移植(RIST)最小化了传统造血干细胞移植的不良反应,并且在rist(TBI-RIST)之前的短时间内施用低剂量全体辐射(TBI)。不同的机构采用不同的TBI-rist行政方法,因为没有研究过此目的,对日本的TBI计划进行了调查。 2015年10月,日本辐射肿瘤学研究小组启动了2010年至2010年至2010年间TBI-rist程序的全国调查。在2010年至2010年之间进行的TBI-RIST程序。在执行TBI的186个机构中,90(48%)回复了调查,其中78名表演TBI-rist。在这些机构的恶性疾病中接受了2488名患者,为1412(56.8%)患者进行白血病,477(19.2%)的恶性淋巴瘤,453(18.2),用于多发性骨髓瘤,44例(1.8%),适用于多个骨髓瘤,和其他恶性疾病的102(4.1%)。此外,206例(52.0%)396名患者(高比例的患者)患有良性疾病的TBI具有增生性贫血。 TBI-RIST设备和治疗方法与用于髓鞘方案的那些类似。常规屏蔽器官包括肺部(43.6%),眼睛(50.0%)和肾脏(10.2%)。卵巢(14.1%),甲状腺(6.4%)和睾丸(16.7%)也经常被屏蔽,可能反映了在儿童中屏蔽生殖器官的重点。 TBI-RIST比良性疾病患者的髓鞘调节更频繁地进行。在用镁钙分析治疗的患者治疗TBI-rist治疗的患者中更频繁地应用生殖器和甲状腺屏蔽。总之,本研究表明,日本TBI-rist的地位,可以帮助将来努力标准化TBI-rist治疗方法,并设计未来的多中心协同研究研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号